Legal Representation
Attorney
Max Vern
USPTO Deadlines
Next Deadline
12 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2005-11-22)
Due Date
November 22, 2025
Grace Period Ends
May 22, 2026
Application History
43 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 24, 2025 | ES71 | I | TEAS SECTION 71 RECEIVED | Loading... |
| Mar 21, 2025 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Nov 22, 2024 | REM4 | E | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | Loading... |
| Jun 5, 2024 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Jun 5, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jun 5, 2024 | EWOR | I | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | Loading... |
| Jun 5, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jun 5, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jun 5, 2024 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jun 5, 2024 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Sep 15, 2023 | ADCH | M | CHANGE OF NAME/ADDRESS REC'D FROM IB | Loading... |
| Apr 15, 2021 | RNWL | P | INTERNATIONAL REGISTRATION RENEWED | Loading... |
| Oct 26, 2017 | ADCH | M | CHANGE OF NAME/ADDRESS REC'D FROM IB | Loading... |
| Sep 8, 2017 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Apr 20, 2017 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Feb 9, 2017 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Feb 9, 2017 | ADCH | M | CHANGE OF NAME/ADDRESS REC'D FROM IB | Loading... |
| Jul 19, 2016 | INNA | R | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | Loading... |
| Jul 19, 2016 | INPR | P | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | Loading... |
| Nov 19, 2015 | NA71 | E | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | Loading... |
| Nov 19, 2015 | 71AG | O | REGISTERED-SEC.71 ACCEPTED | Loading... |
| Nov 17, 2015 | ES71 | I | TEAS SECTION 71 RECEIVED | Loading... |
| Mar 27, 2014 | INNP | P | PARTIAL INVALIDATION PROCESSED BY THE IB | Loading... |
| Mar 4, 2014 | INPS | P | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | Loading... |
| Mar 27, 2013 | INPR | P | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | Loading... |
| Jun 27, 2012 | NA71 | E | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | Loading... |
| Jun 27, 2012 | 71AG | O | REGISTERED-SEC.71 ACCEPTED | Loading... |
| Jun 27, 2012 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| May 3, 2012 | ES71 | I | TEAS SECTION 71 RECEIVED | Loading... |
| Nov 11, 2011 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Feb 25, 2011 | RNWL | P | INTERNATIONAL REGISTRATION RENEWED | Loading... |
| Jul 15, 2010 | ADCH | M | CHANGE OF NAME/ADDRESS REC'D FROM IB | Loading... |
| Jun 16, 2006 | LIMG | M | LIMITATION OF GOODS RECEIVED FROM IB | Loading... |
| Feb 24, 2006 | ADCH | M | CHANGE OF NAME/ADDRESS REC'D FROM IB | Loading... |
| Nov 22, 2005 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Aug 30, 2005 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 10, 2005 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| May 12, 2005 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| May 6, 2005 | ALIE | A | ASSIGNED TO LIE | Loading... |
| May 2, 2005 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 2, 2005 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 10, 2004 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
| Dec 9, 2004 | SDRC | M | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | Loading... |
Detailed Classifications
Class 001
Chemicals used in industry and science, namely, monoclonal antibodies for in vivo or in vitro scientific research and development regarding cancer [ AIDS (acquired immune deficiency syndrome), and other infectious diseases, autoimmune diseases, and cardiovascular diseases ]
Class 005
Pharmaceutical preparations based on human monoclonal antibodies for the treatment of cancer [ AIDS (acquired immune deficiency syndrome), and other infectious diseases, autoimmune diseases, and cardiovascular diseases ]
Classification
International Classes
001
005